# Liraglutide and systolic blood pressure.

> PubMed lists PMID 30515941 in Journal of clinical hypertension (Greenwich, Conn.) as Letter, with publication-date metadata of 2018-12-05 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30515941-liraglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-07
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30515941-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30515941-liraglutide-v1.json
- Content SHA-256: `8804e1e927849051c6de438c801cebefc8f1997e5ab262eafdfec066770ac21d`

## Claims and source pins

### Headline

Liraglutide and systolic blood pressure. ([`pubmed-observation-pmid-30515941-2026-07-07-36a1024df791`](#source-pubmed-observation-pmid-30515941-2026-07-07-36a1024df791))

### Summary

PubMed lists PMID 30515941 in Journal of clinical hypertension (Greenwich, Conn.) as Letter, with publication-date metadata of 2018-12-05 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30515941-2026-07-07-36a1024df791`](#source-pubmed-observation-pmid-30515941-2026-07-07-36a1024df791))

### Paragraph 1

PubMed lists PMID 30515941 in Journal of clinical hypertension (Greenwich, Conn.) as Letter, with publication-date metadata of 2018-12-05 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30515941-2026-07-07-36a1024df791`](#source-pubmed-observation-pmid-30515941-2026-07-07-36a1024df791))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30515941-2026-07-07-36a1024df791`](#source-pubmed-observation-pmid-30515941-2026-07-07-36a1024df791))

## Sources

<a id="source-pubmed-observation-pmid-30515941-2026-07-07-36a1024df791"></a>
- **Liraglutide and systolic blood pressure. · retained source version 1:2026-07-07:current:36a1024df7911df730d9ba60c06db474cdbe8042b84931c61a16c137e3bc736c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30515941/) (`pubmed-observation-pmid-30515941-2026-07-07-36a1024df791`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Liraglutide and systolic blood pressure." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30515941-liraglutide-v1.json SHA-256: 8804e1e927849051c6de438c801cebefc8f1997e5ab262eafdfec066770ac21d.